Why Mesoblast, Newcrest, Sezzle & Telstra shares are racing higher

Mesoblast limited (ASX:MSB) and Telstra Corporation Ltd (ASX:TLS) shares are two of four racing higher on Thursday…

| More on:
hand on touch screen lit up by a share price chart moving higher

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been a bumpy ride for the S&P/ASX 200 Index (ASX: XJO) on Thursday. After a number of ups and downs, in late morning trade the benchmark index is down slightly to 6,852.8 points.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are racing higher:

Mesoblast limited (ASX: MSB)

The Mesoblast share price is up 4.5% to $2.68 following the release of a trial update. According to the release, the results of a phase three trial indicate that a single injection of rexlemestrocel-L may provide a safe, durable, and effective opioid-sparing therapy for patients with chronic inflammatory back pain due to degenerative disc disease. The study notes that the greatest benefits were seen when administered earlier in the disease process before irreversible fibrosis of the intervertebral disc has occurred.

Newcrest Mining Ltd (ASX: NCM)

The Newcrest share price has climbed 5.5% to $26.61. This follows the release of the gold miner's half year results this morning. For the six months ended 31 December, Newcrest reported a 21% increase in revenue to US$2.17 billion. Things were even better on the bottom line, with the company reporting a 98% jump in underlying profit to US$553 million. This was driven by a 48% increase in its all-in sustaining cost (AISC) margin to US$842 per ounce.

Sezzle Inc (ASX: SZL)

The Sezzle share price is up 4.5% to $10.97. Investors have been buying the buy now pay later provider's shares following the announcement of a new receivables funding facility. The US$250 million facility will be used to support the expansion of the company's business in the United States and Canada. Positively, the new facility also lowers its cost of funding, which will provide a positive effect on Sezzle's net transaction margin over time.

Telstra Corporation Ltd (ASX: TLS)

The Telstra share price is up almost 3% to $3.26. The catalyst for this was the release of a solid half year result this morning. Investors appear pleased that the Telstra board plans to maintain its 16 cents per share fully franked dividend in FY 2021. Management's bold growth plans also appear to have caught the eye of investors.

Should you invest $1,000 in Clinuvel Pharmaceuticals right now?

Before you buy Clinuvel Pharmaceuticals shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Clinuvel Pharmaceuticals wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Sezzle Inc. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool Australia has recommended Sezzle Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Happy woman working on a laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a pleasant end to the trading week for investors this Friday.

Read more »

A happy investor sits at his desk in front of his laptop and does the mexican wave with his arms to celebrate the returns from his ASX dividend shares
Share Gainers

Why Chrysos, GQG Partners, Macquarie, and Webjet shares are storming higher today

These shares are ending the week on a positive note. But why?

Read more »

A young man sits at his desk working on his laptop with a big smile on his face.
Share Gainers

The top 3 ASX 200 trades since the Liberation Day dip

These companies are up at least 35% in just over a month.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Share Gainers

Boss Energy shares have rocketed 90% in a month. Here's why

The massive rally in Boss Energy shares will be painful to the host of short sellers betting against the uranium…

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors sent the market higher once again today.

Read more »

Rising gold share price represented by a green arrow on piles of gold block.
Gold

3 reasons to buy this surging ASX All Ords gold stock today

The ASX All Ords gold stock has doubled investors’ money in 12 months, and this leading expert forecasts more outperformance…

Read more »

Two colleagues at work looking at a tablet and smiling at a rising share price.
Share Gainers

Why Generation Development, Orica, Pro Medicus, and Zip shares are storming higher today

These shares are having a strong session on Thursday. But why?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 114% in a year, why is the Pro Medicus share price leaping higher again on Thursday?

Pro Medicus shares are back in form today and leaping ahead. Here’s why.

Read more »